Program Timeline Injections are typically administered once or twice daily
A DXA scan measures bone mineral density at the hip and lumbar spine, the same locations where the Hansen semaglutide trial documented statistically significant bone loss
Long-term use : Is the medication safe for long-term use
Contact a doctor if bright yellow urine persists, appears with other symptoms like fatigue or nausea, or occurs with urinary changes such as pain, blood, or unusual smell or consistency
Although Novo and Hims later resolved their dispute, that enforcement signal still matters because it clarified where FDA was drawing the line on compounded GLP-1 marketing
In both groups, distress is driven less by weight loss and more by a sudden change in appearance